Beitrag

09.11.2026

iFIT Distinguished Lecture 2026 with Dr. Korbinian Kropp

🎤 iFIT Seminar Series 2026: Exploiting PCBP2-Mediated RNA Regulation to Enhance TCR-Based Immunotherapies
How can we make tumor cells more vulnerable to T cell-mediated killing and improve the effectiveness of cancer immunotherapies?
On November 9, 2026, we were delighted to welcome Dr. Korbinian Kropp, MD from Memorial Sloan Kettering Cancer Center (MSKCC), New York, USA, to our iFIT Seminar Series in Tübingen. Prof. Dr. med. Juliane S. Walz, co-spokesperson of the iFIT - Cluster of Excellence at the Universitätsklinikum Tübingen, introduced Dr. Kropp and welcomed him to the seminar.

🔬 In his lecture, Dr. Kropp presented insights into the development of T cell receptor (TCR)-based immunotherapies, highlighting how tumor cells can be targeted through HLA class II-restricted T cell responses, potentially overcoming certain limitations of conventional HLA class I-dependent approaches.

🔬 A central focus was the identification of molecular mechanisms that influence tumor cell sensitivity to CD4+ T cell-mediated killing. Using genome-wide and focused CRISPR screens, his team identified the RNA-binding protein PCBP2 as an important regulator of tumor cell susceptibility to immune attack.
His research demonstrated that PCBP2 deletion increases tumor cell sensitivity to TNF- and IFNγ-induced apoptosis, enhancing CD4+ T cell-mediated tumor killing. Further investigations revealed distinct functions of PCBP2 isoforms and identified U2AF2 as a potential downstream regulator of these effects.

💡 Importantly, these findings were also supported by in vivo models, highlighting the potential of targeting RNA regulatory mechanisms to improve the effectiveness of T cell-based cancer immunotherapies.

In the second part of his talk, Dr. Kropp highlighted emerging research directions and future opportunities for innovative cancer immunotherapies.

👏 Many thanks to Dr. Korbinian Kropp for sharing his exciting research and for the stimulating scientific discussion with the iFIT community!